Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-09-14

Clinical Trial Update: Prevention of Intrauterine Growth Retardation in Burkina Faso: the Malaria Component [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating malaria prevention to reduce intrauterine growth restriction in Burkina Faso. The malaria component of the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Institute of Tropical Medicine, Belgium | Conditions: Malaria, Malaria in Pregnancy | Phase 4 | Status: COMPLETED